Comprehensive profiling of cancer neoantigens from aberrant RNA splicing
Background
Cancer neoantigens arise from protein-altering somatic mutations in tumor and rank among the most promising next-generation immuno-oncology agents when used in combination with immune checkpoint inhibitors. We previously developed a computa…